美泊利单抗
Mepolizumab.
作者信息
Cada Dennis J, Bindler Ross J, Baker Danial E
出版信息
Hosp Pharm. 2016 May;51(5):405-14. doi: 10.1310/hpj5105-405.
Each month, subscribers to The Formulary Monograph Service receive 5 to 6 well-documented monographs on drugs that are newly released or are in late phase 3 trials. The monographs are targeted to Pharmacy & Therapeutics Committees. Subscribers also receive monthly 1-page summary monographs on agents that are useful for agendas and pharmacy/nursing in-services. A comprehensive target drug utilization evaluation/medication use evaluation (DUE/MUE) is also provided each month. With a subscription, the monographs are sent in print and are also available on-line. Monographs can be customized to meet the needs of a facility. A drug class review is now published monthly with The Formulary Monograph Service. Through the cooperation of The Formulary, Hospital Pharmacy publishes selected reviews in this column. For more information about The Formulary Monograph Service, contact Wolters Kluwer customer service at 866-397-3433. The May 2016 monograph topics are sugammadex, lesinurad, selexipag, sebelipase alfa, and alectinib. The Safey MUE is on sugammadex.
每月，《处方集专论服务》的订阅者会收到5至6篇关于新发布或处于3期临床试验后期药物的详细专论。这些专论面向药学与治疗学委员会。订阅者每月还会收到1页的关于对议程以及药学/护理在职培训有用药物的总结专论。每月还会提供一份全面的目标药物利用评估/用药评估（DUE/MUE）。订阅后，专论会以印刷品形式发送，也可在线获取。专论可进行定制以满足机构需求。现在每月会随《处方集专论服务》发布一次药物类别综述。通过《处方集》的合作，《医院药学》在本专栏发表精选综述。有关《处方集专论服务》的更多信息，请致电866 - 397 - 3433联系威科集团客服。2016年5月的专论主题为舒更葡糖钠、雷西纳德、司来帕格、 sebelipase alfa和阿来替尼。安全用药评估主题是舒更葡糖钠。
Zotero 插件